MedTrace Logo

ESP Block VS TAP in Laparoscopic Hysterectomy

NCT04003987 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2022-07-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the difference between two different pain control methods in patients who will be having a hysterectomy surgery. By collecting this data, we aim to show improved postoperative pain scores, decreased opioid needs, and decreased opioid side effects (nausea, sedation, ileus, urinary retention, respiratory depression).

Conditions

  • Hysterectomy

Interventions

DRUG

Liposomal bupivacaine

20ml

DRUG

bupivacaine, 0.125%

60ml

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Yar Yeap, MD · Indiana University Hospital

  • Matthew Warner, MD · Indiana University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2021-03-04
Completion
2021-03-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04003987 on ClinicalTrials.gov